Juliet Reid

2.6k total citations · 1 hit paper
13 papers, 2.0k citations indexed

About

Juliet Reid is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Juliet Reid has authored 13 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Juliet Reid's work include Urticaria and Related Conditions (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Juliet Reid is often cited by papers focused on Urticaria and Related Conditions (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Juliet Reid collaborates with scholars based in United Kingdom, United States and Italy. Juliet Reid's co-authors include Tony Kouzarides, Andrew J. Bannister, Eric A. Miska, Alexander Brehm, Dennis J. McCance, Kevin Struhl, Patrick O. Brown, Vishwanath R. Iyer, Søren Jensby Nielsen and Zarmik Moqtaderi and has published in prestigious journals such as Nature, The EMBO Journal and Molecular Cell.

In The Last Decade

Juliet Reid

13 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retinoblastoma protein recruits histone deacetylase to repress transcription

1998 1.0k citations Alexander Brehm, Eric A. Miska et al. Nature profile →

Peers

Countries citing papers authored by Juliet Reid

Since Specialization

Citations

This map shows the geographic impact of Juliet Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliet Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliet Reid more than expected).

Fields of papers citing papers by Juliet Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliet Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliet Reid. The network helps show where Juliet Reid may publish in the future.

Co-authorship network of co-authors of Juliet Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Juliet Reid. A scholar is included among the top collaborators of Juliet Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliet Reid. Juliet Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis 2022 ·Lara D. Veeken ·Christopher P. Denton, Francesco Del Galdo, Dinesh Khanna, Madelon C Vonk, Leland W.K. Chung, Sindhu R. Johnson, John Varga, Daniel E. Furst, (unknown), Chiara Zecchin, Eszter Csomor, Amy S. Lee, Nicolas Wisniacki, Shaun Flint, Juliet Reid	20
2	In vivo affinity and target engagement in skin and blood in a first‐time‐in‐human study of an anti‐oncostatin M monoclonal antibody 2018 ·British Journal of Clinical Pharmacology ·Juliet Reid, Stefano Zamuner, (unknown), (unknown), (unknown), Maria Feeney, Chiara Zecchin, Disala Fernando, Nicolas Wisniacki	33
3	A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus 2016 ·PLoS ONE ·(unknown), Juliet Reid, Prafull Mistry, Stephen DeWall, (unknown), Phil Ambery, Blas Gil Extremera	63
4	Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects 2014 ·International Journal of Clinical Pharmacology and Therapeutics ·Prafull Mistry, Juliet Reid, Isabelle Pouliquen, Simon McHugh, (unknown), Stephen DeWall, Adam Taylor, Xin Tong, (unknown), (unknown)	34
5	Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy 2011 ·Human Molecular Genetics ·Agatha Schlüter, Lluı́s Espinosa, Stéphane Fourcade, Jorge Galino, Eva López, Ekaterina V. Ilieva, Laia Morató, Muriel Asheuer, Ted A. Cook, Alistair S. McLaren, Juliet Reid, F. M. Kelly, Stewart Bates, Patrick Aubourg, Elena Galea, Aurora Pujol	60
6	Expression Profiling of a Genetic Animal Model of Depression Reveals Novel Molecular Pathways Underlying Depressive-Like Behaviours 2010 ·PLoS ONE ·Ekaterini Blaveri, F. M. Kelly, Alessandra Mallei, (unknown), Adam Taylor, Juliet Reid, Maria Razzoli, Lucia Carboni, Chiara Piubelli, Laura Musazzi, (unknown), Aleksander A. Mathé, Maurizio Popoli, Enrico Domenici, Stewart Bates	38
7	Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function 2009 ·Molecular Psychiatry ·Peter R. Maycox, F. M. Kelly, Adam Taylor, Stewart Bates, Juliet Reid, (unknown), Michael R. Barnes, Christopher Larminie, Nick D. Jones, Mark Lennon, Ceri H. Davies, Jim J. Hagan, Carol A. Scorer, (unknown), (unknown), S.R. Hirsch, Ann Mortimer, (unknown), Jackie de Belleroche	150
8	Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation 2009 ·Synapse ·(unknown), Carol A. Jennings, Melanie J. Robbins, Jane E. Cluderay, Jackie Cilia, Juliet Reid, Adam Taylor, Declan N.C. Jones, Piers C. Emson, Eric Southam	40
9	Eaf3 Regulates the Global Pattern of Histone Acetylation in Saccharomyces cerevisiae 2003 ·Molecular and Cellular Biology ·Juliet Reid, Zarmik Moqtaderi, Kevin Struhl	61
10	Coordinate Regulation of Yeast Ribosomal Protein Genes Is Associated with Targeted Recruitment of Esa1 Histone Acetylase 2000 ·Molecular Cell ·Juliet Reid, Vishwanath R. Iyer, Patrick O. Brown, Kevin Struhl	245
11	The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth 1999 ·The EMBO Journal ·Alexander Brehm, Søren Jensby Nielsen, Eric A. Miska, Dennis J. McCance, Juliet Reid, Andrew J. Bannister, Tony Kouzarides	244
12	The cell cycle-regulating transcription factors E2F-RB. 1999 ·PubMed ·Alexander Brehm, Eric A. Miska, Juliet Reid, Andrew J. Bannister, Tony Kouzarides	13
13	Retinoblastoma protein recruits histone deacetylase to repress transcription breakdown → 1998 ·Nature ·Alexander Brehm, Eric A. Miska, Dennis J. McCance, Juliet Reid, Andrew J. Bannister, Tony Kouzarides	1021

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact